{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:15:39Z","timestamp":1793196939163,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.diabres.2022.109994","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T12:11:35Z","timestamp":1657800695000},"page":"109994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["\u03b2-cell function and insulin sensitivity contributions on incident diabetes in patients with endogenous Cushing\u2019s syndrome"],"prefix":"10.1016","volume":"190","author":[{"given":"Ziye","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.diabres.2022.109994_b0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.diabres.2022.109994_b0010","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2022.109994_b0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/er.2016-1105","article-title":"Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management","volume":"38","author":"Scaroni","year":"2017","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.diabres.2022.109994_b0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tem.2011.09.001","article-title":"Diabetes in Cushing syndrome: basic and clinical aspects","volume":"22","author":"Mazziotti","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.diabres.2022.109994_b0025","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2009-0612","article-title":"Approach to the patient with possible Cushing's syndrome","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.diabres.2022.109994_b0030","doi-asserted-by":"crossref","first-page":"M133","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in Cushing's syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2022.109994_b0035","doi-asserted-by":"crossref","first-page":"E681","DOI":"10.1152\/ajpendo.90931.2008","article-title":"High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets","volume":"296","author":"Rafacho","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.diabres.2022.109994_b0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0030-1269896","article-title":"Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats","volume":"43","author":"Rafacho","year":"2011","journal-title":"Horm Metab Res"},{"issue":"3","key":"10.1016\/j.diabres.2022.109994_b0045","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/JOE-14-0373","article-title":"Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes","volume":"223","author":"Rafacho","year":"2014","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2022.109994_b0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-13-0754","article-title":"Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?","volume":"170","author":"Giordano","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2022.109994_b0055","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-S33.","DOI":"10.2337\/dc21-S002"},{"issue":"7","key":"10.1016\/j.diabres.2022.109994_b0060","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diacare.20.7.1087","article-title":"The homeostasis model in the San Antonio Heart Study","volume":"20","author":"Haffner","year":"1997","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2022.109994_b0065","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2022.109994_b0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2022.109994_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11892-017-0860-9","article-title":"Diabetes in Cushing Disease","volume":"17","author":"Mazziotti","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"6","key":"10.1016\/j.diabres.2022.109994_b0080","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.diabres.2022.109994_b0085","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1507\/endocrj.EJ15-0748","article-title":"Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome","volume":"63","author":"Otsuki","year":"2016","journal-title":"Endocr J"},{"issue":"10","key":"10.1016\/j.diabres.2022.109994_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258476","article-title":"Reproducibility and discrimination of different indices of insulin sensitivity and insulin secretion","volume":"16","author":"Hudak","year":"2021","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.diabres.2022.109994_b0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s125-002-8244-y","article-title":"Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans","volume":"45","author":"Hollingdal","year":"2002","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.diabres.2022.109994_b0100","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.2337\/diabetes.51.10.2895","article-title":"Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin","volume":"51","author":"Willi","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.diabres.2022.109994_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030210","article-title":"Novel transgenic mice for inducible gene overexpression in pancreatic cells define glucocorticoid receptor-mediated regulations of beta cells","volume":"7","author":"Blondeau","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.diabres.2022.109994_b0110","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00125-006-0449-3","article-title":"Glucocorticoid signalling affects pancreatic development through both direct and indirect effects","volume":"49","author":"Gesina","year":"2006","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabres.2022.109994_b0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2183\/pjab.86.563","article-title":"Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment","volume":"86","author":"Seino","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"4","key":"10.1016\/j.diabres.2022.109994_b0120","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00125-011-2422-z","article-title":"Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death","volume":"55","author":"Reich","year":"2012","journal-title":"Diabetologia"},{"issue":"1\u20132","key":"10.1016\/j.diabres.2022.109994_b0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mce.2013.12.010","article-title":"Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and \u03b2-cells","volume":"383","author":"Fransson","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"10.1016\/j.diabres.2022.109994_b0130","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cellsig.2011.06.002","article-title":"Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells","volume":"23","author":"Linssen","year":"2011","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.diabres.2022.109994_b0135","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/endo-81-3-558","article-title":"ACTH-mediated insulin secretion: effect of aminophylline","volume":"81","author":"Lebovitz","year":"1967","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.diabres.2022.109994_b0140","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/endo-93-3-602","article-title":"Dynamics of insulin release by perfused rat pancreases: effects of hypophysectomy, growth hormone, adrenocorticotropic hormone, and hydrocortisone","volume":"93","author":"Curry","year":"1973","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.diabres.2022.109994_b0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0742-8413(98)00008-5","article-title":"Modulatory effect of hormones on insulin secretion in vitro in the toad","volume":"120","author":"Flores","year":"1998","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2022.109994_b0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/joe.0.1800155","article-title":"ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans","volume":"180","author":"Al-Majed","year":"2004","journal-title":"J Endocrinol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:07Z","timestamp":1759173787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"alternative-id":["S0168822722008087"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109994","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-cell function and insulin sensitivity contributions on incident diabetes in patients with endogenous Cushing\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109994"}}